pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4640 |
Genomic Coordinates | chr6: 30890883 - 30890972 |
Description | Homo sapiens miR-4640 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4640-5p | ||||||||||||||||||||||||
Sequence | 9| UGGGCCAGGGAGCAGCUGGUGGG |31 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SRCIN1 | ||||||||||||||||||||
Synonyms | P140, SNIP | ||||||||||||||||||||
Description | SRC kinase signaling inhibitor 1 | ||||||||||||||||||||
Transcript | NM_025248 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SRCIN1 | |||||||||||||||||||||
3'UTR of SRCIN1 (miRNA target sites are highlighted) |
>SRCIN1|NM_025248|3'UTR 1 AAGCCCCTCACCCCGCTGCCCCGCCTGTCCCCCTCCCTCACTCCTGCCATTTCTCCCCTCTCTTCCTTCATCTCCACCCC 81 ACCCCACCCTACTCTCCAGACGCCCTGAGGGGTGTGCCCTGAAGAGGAGGGTGCGGCCCTCCTCAGCGACCCCTACCCAT 161 CATCTGTTGGTGTTTTTGGTTTTGTTTTTTTTTTTTTTTTTAACAATTAACTTTTAATTATCTTTTTTTAAACAGTAAAA 241 CTAAAAACCAAACACACCACCTTCCTTGATCCCAGCTGGCCTCTCGCTGGCCGCACCTGTCACATCTCTCCTTCTTCTCT 321 TTCACCACTCTTTCCCCCAGTCCATCCTGAAGCTCCTGCACCCCCTTCCCGCCTTCCCCTCACTTCCCAAGAATACTCCA 401 AACAAACTCTGAACCACGGAGACTTGGAGCAGTGGGAGACCCCTCTCCCGTTTCTCGATACCTTCCTGGAGGAACGCGGG 481 GACATCGGACCAACCCATACATCAAGCCAGAGAGCGGGGCTTAGGGAGACTGGCCTTGGAGATGCCCCACTCCCTGTCTA 561 AGCTCCGACAAGACTGTGACTTCCTCTGTGGCTGCTCTGCCTCCTCCCACTCACACCCAAGTGGGCCTGGAGTAGAGACG 641 GACAGGCTGGAGACGAGGCCGGAGTTTGAGAGGCCTCAGGGTGGGTGTGAGGCCATGGAGTCTGTATCCCTGGGGAGGCG 721 CTGGCCTCCTGGGCCTTGCCGTCCAGTGGGGAGTGGAGGGCAGAGGCCCTTTGGTCTGCTGGCTGTGGAGGGTGGGTTGC 801 ACGGACAGCCGGATATCGGGGACACTGCCTTGGGAGAGGGCGGCCCGGACGGGTATTTGGTACTTTTAGTTTCCTGATTT 881 AGCACTTTAAATGGCATTAACTTATTGAATGGGGATGGGGTGGGCAAGAGTGAGGGGCCTAGAAAACCAGGTTTTGTGGC 961 TTGCAGTTGGGGGAAGGGTCTGGTTTGAGGGAAATGGGAGGGTCGAGAGGGGCTTGACGGGGAGCACTGAAGACACCTGG 1041 GACCCGCAGGTGGGGTGACTTGAACTTCAGTCATCCTCTTGGCAATTTGAGGGTTTTCCCAGGAAAGGATGAGACGTAGT 1121 TTTTCAATGGGGCTCTGGTGACCCTGGTGAGATGTCTGAAGGTCCCTGAGGCCTGACCATCCAGCCAGCGCCCCTGGCCT 1201 GTGGACGCCCTGCCTGCCCTGCAGAGGCGGTTGGCAGTGCCGCCTGGCTTTTGGCCGGGTCCTGGGGAGGCAGAGAGAGG 1281 CCAATTTTGGTTCTCACTCCTGGCCCCCCAGAGGGCACAGTGAGGAGCCGGTAGGGAGAGGATAGGAGAAGAGGAGGAGG 1361 AGGAGCGGGGTCCCCGGCCGCAGGATTCCCACTTGGAGCACAAAGTGAAGTAAGCACAGGGGAGGGGGACTAGAATCAGT 1441 CCCCCATAGCAAGCACAGAAAGGAGGAGCTGCGCAGAAGGCAGAGCCCCCCAGACCCTGGGGCCTGGCTGGGGAAGGTCC 1521 GCACCTGGGGAGAGCTGGGAGCTGTTGAAGGTTTGGGGGGAGGGGAAACGGGTTGTGTTTCTTCATTTCTTTTTTTGTTT 1601 TTGCCTTTGTTGGTTCATCCTTGTTTTCTAGCTTTGGATCATTTTTGTACCAAGGCGAGCAAGCCTTTTTGAAAAATAAC 1681 AAAAGAGGAAAAAAAAAATCCCTCCTGGAAAAAAAAAAAAACCCTGGAAAATAGAAAAAAAAAAAAGGACCTCATAAATG 1761 ATGCAATTACTTTTAATTGCAGGCAACTCTTTACATTTAAGTGAAGTGTCTTAACATTTTATATTGTTTTAAAAATATAT 1841 TTACATATTATATATATAATATACGTAATATAAATATATATAAATATTTAAAAAAGAAAAAAAAAAGAAAACCACGGCAC 1921 TCTCCCTGGCCACTGTTTTGGCGGGGGAGGGGGGCTGGGGGGCGGGCACGTCGGCCTGGCTTCTGTGGTCCCAGTGAAAT 2001 GGTCTGGTTTGATTTGGCTGTACAGAGACCCCCTGACTTGGGAGGGGAGGGGGGAGTGGTGCCCCCTCCTCCCTCCACTC 2081 CATTACTCTCTGCTTGCTACTTCGCTTGCCCCCAGCTCCCACCCTCAGCCCTGTGACTGGAATGTGTGCCCCACCGTCAT 2161 TGTCCTGAGTTGAATGTCCCTTTGTGGGGGAGGTGGGGGGGGCAGTGTCCATCCACGAAGGGGCAGAAGGAGGGAGCCAC 2241 GTGCCCCGCCCCACCCGCTCGGGTGAAGCCCAGTGGGATTTGCATCTTTCTTTCTCTTTGGTTCCTGCACATTTATGGGC 2321 TGGGAGGCATCCGTGTGGAATTGCGTGCAGCCTGTGTGTGTGCTGGCACAAGCCCATGCACTGTGTGTGCAGACGCATGG 2401 GGCCTGCACCCACAGGCATGGCCGAGCACATGTGTGGGGGAAGGCGTGGGCACATAGGTGCATGTAACCTGTTTGGGCAT 2481 TGGCACGTGCCTACCTGCATGTTAGCGTGAGAGGAGCTTTGTGTGTGAGAACATGTGTAATGTGTGTGCAGACATGCCGA 2561 GAGCCAGAGACTTGTGTGTGGGCCACGTACATGTGGATAGAGACGCATACATGGAGGTGCATGTAATCTGTGTCTCCGAG 2641 TGTGTGTGTGCAGGTATGTGTGCTGGTGCAGACCCAAGTGTGTGGGTGTGCCTCTGTGTGCGTGTGTTCCATCATCCCTG 2721 CACCACTGGCTCCAGATCCCTTCCTGAGCCCCCGTCCCCGCTGGCCCTCTCACAGCCTGCAGCACATCAGTGCCCCCAGC 2801 TGCATGCGCCTCGCTGCTCTGTCCATCAGTGTGTGCTTGACCAAGAGAAAACTAAGACGTCTCGGGGGACCCCTGTACCT 2881 GGTCCTCTCAGCCCCCGCCCACTGTGCTGTGTTACTCGCATGGGGGATTTCCTGCCCCTTCCACAATATGCTGTTTCCCC 2961 AGGAGCCTCAGGCCTGAGGCTCTGAGTGGGGTCCCCAGGGGGCCCCCCGGGGTGAGCCCCGGCTCCACACCCTGCCCCAT 3041 CCACCCTGTAGGGCCCATGTTGGTGTAGCAGTGATGGCTTCTGTGGATATTCTGTGACCTCTGTCGGTGTAACTTGACAA 3121 TTTCTAAATGGAAAAGGGTTGCTGTGTTTTCTCTGTCTCTCTTTTTTAATGTCCTTTTTTCTTCTCCCCCGCTCCCTGCT 3201 CTCTTTCCTTTTCAGTTTTTCTAGCCAAGTGTTTGGGGCTTTAATAAAACTTGTTTCTTTTTCCTCTCCTGGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C8166 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_025248 | 3UTR | CUCCUGGCCCCCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_025248 | 3UTR | CUCCUGGCCCCCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000264659.7 | 3UTR | AGCCCCCGUCCCCGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
87 hsa-miR-4640-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT100106 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT248144 | LMBR1L | limb development membrane protein 1 like | 2 | 2 | ||||||||
MIRT327062 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT347231 | GATAD2A | GATA zinc finger domain containing 2A | 2 | 2 | ||||||||
MIRT450221 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT451264 | NDUFA11 | NADH:ubiquinone oxidoreductase subunit A11 | 2 | 2 | ||||||||
MIRT452701 | C1orf226 | chromosome 1 open reading frame 226 | 2 | 2 | ||||||||
MIRT453212 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT454822 | POLR2J3 | RNA polymerase II subunit J3 | 2 | 2 | ||||||||
MIRT454883 | RAD50 | RAD50 double strand break repair protein | 2 | 2 | ||||||||
MIRT455783 | TAF8 | TATA-box binding protein associated factor 8 | 2 | 2 | ||||||||
MIRT455858 | TMEM254 | transmembrane protein 254 | 2 | 2 | ||||||||
MIRT457615 | UPK3BL | uroplakin 3B like 1 | 2 | 2 | ||||||||
MIRT457822 | ITPRIP | inositol 1,4,5-trisphosphate receptor interacting protein | 2 | 4 | ||||||||
MIRT458344 | NOC2L | NOC2 like nucleolar associated transcriptional repressor | 2 | 2 | ||||||||
MIRT458376 | ITM2C | integral membrane protein 2C | 2 | 2 | ||||||||
MIRT458928 | SAMD4B | sterile alpha motif domain containing 4B | 2 | 2 | ||||||||
MIRT459066 | WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 2 | 2 | ||||||||
MIRT460138 | ASB16 | ankyrin repeat and SOCS box containing 16 | 2 | 2 | ||||||||
MIRT460818 | FSTL4 | follistatin like 4 | 2 | 2 | ||||||||
MIRT461285 | COX10 | COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor | 2 | 2 | ||||||||
MIRT462738 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT464556 | UBTF | upstream binding transcription factor, RNA polymerase I | 2 | 2 | ||||||||
MIRT477910 | DUSP2 | dual specificity phosphatase 2 | 2 | 2 | ||||||||
MIRT479073 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | 2 | 4 | ||||||||
MIRT479534 | CDC5L | cell division cycle 5 like | 2 | 4 | ||||||||
MIRT485628 | EEPD1 | endonuclease/exonuclease/phosphatase family domain containing 1 | 2 | 2 | ||||||||
MIRT489896 | PPIC | peptidylprolyl isomerase C | 2 | 4 | ||||||||
MIRT490737 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT491201 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 4 | ||||||||
MIRT492681 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | 2 | 2 | ||||||||
MIRT494593 | ATG7 | autophagy related 7 | 2 | 2 | ||||||||
MIRT495061 | PADI3 | peptidyl arginine deiminase 3 | 2 | 4 | ||||||||
MIRT496623 | TMEM67 | transmembrane protein 67 | 2 | 2 | ||||||||
MIRT497177 | ZBTB40 | zinc finger and BTB domain containing 40 | 2 | 2 | ||||||||
MIRT498217 | TLN2 | talin 2 | 2 | 2 | ||||||||
MIRT498306 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT499668 | NPHP3 | nephrocystin 3 | 2 | 2 | ||||||||
MIRT508080 | ANKRD52 | ankyrin repeat domain 52 | 2 | 2 | ||||||||
MIRT509707 | ANKRD23 | ankyrin repeat domain 23 | 2 | 2 | ||||||||
MIRT509841 | FOS | Fos proto-oncogene, AP-1 transcription factor subunit | 2 | 2 | ||||||||
MIRT512814 | ARRDC2 | arrestin domain containing 2 | 2 | 2 | ||||||||
MIRT513353 | SLIT1 | slit guidance ligand 1 | 2 | 2 | ||||||||
MIRT514293 | FXYD5 | FXYD domain containing ion transport regulator 5 | 2 | 2 | ||||||||
MIRT516598 | FAM89A | family with sequence similarity 89 member A | 2 | 4 | ||||||||
MIRT516616 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT518348 | CCL5 | C-C motif chemokine ligand 5 | 2 | 2 | ||||||||
MIRT520130 | WSB1 | WD repeat and SOCS box containing 1 | 2 | 2 | ||||||||
MIRT522072 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT526461 | OSBPL5 | oxysterol binding protein like 5 | 2 | 2 | ||||||||
MIRT528278 | MBL2 | mannose binding lectin 2 | 2 | 2 | ||||||||
MIRT534844 | RAB15 | RAB15, member RAS oncogene family | 2 | 4 | ||||||||
MIRT542245 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT543299 | ZNF585B | zinc finger protein 585B | 2 | 2 | ||||||||
MIRT552456 | ZNF410 | zinc finger protein 410 | 2 | 2 | ||||||||
MIRT553641 | TJAP1 | tight junction associated protein 1 | 2 | 2 | ||||||||
MIRT557103 | HOXA3 | homeobox A3 | 2 | 2 | ||||||||
MIRT570782 | FANCA | Fanconi anemia complementation group A | 2 | 2 | ||||||||
MIRT630912 | ZMAT2 | zinc finger matrin-type 2 | 2 | 2 | ||||||||
MIRT631034 | ZNF878 | zinc finger protein 878 | 2 | 2 | ||||||||
MIRT639017 | AAK1 | AP2 associated kinase 1 | 2 | 2 | ||||||||
MIRT648596 | ZYG11B | zyg-11 family member B, cell cycle regulator | 2 | 2 | ||||||||
MIRT648939 | ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | 2 | 2 | ||||||||
MIRT652834 | TACO1 | translational activator of cytochrome c oxidase I | 2 | 2 | ||||||||
MIRT659347 | CSRP1 | cysteine and glycine rich protein 1 | 2 | 2 | ||||||||
MIRT664163 | APOBEC3F | apolipoprotein B mRNA editing enzyme catalytic subunit 3F | 2 | 2 | ||||||||
MIRT670511 | ZSCAN22 | zinc finger and SCAN domain containing 22 | 2 | 2 | ||||||||
MIRT671246 | TMEM41B | transmembrane protein 41B | 2 | 2 | ||||||||
MIRT672120 | ATP6V0A2 | ATPase H+ transporting V0 subunit a2 | 2 | 2 | ||||||||
MIRT672313 | CD3D | CD3d molecule | 2 | 2 | ||||||||
MIRT672543 | BRMS1L | breast cancer metastasis-suppressor 1 like | 2 | 2 | ||||||||
MIRT673036 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 2 | ||||||||
MIRT673814 | DARS | aspartyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT674858 | GINM1 | glycoprotein integral membrane 1 | 2 | 2 | ||||||||
MIRT674970 | SH3BP2 | SH3 domain binding protein 2 | 2 | 2 | ||||||||
MIRT675185 | KIF1C | kinesin family member 1C | 2 | 2 | ||||||||
MIRT675219 | UGDH | UDP-glucose 6-dehydrogenase | 2 | 2 | ||||||||
MIRT675558 | MED16 | mediator complex subunit 16 | 2 | 2 | ||||||||
MIRT682566 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 2 | 2 | ||||||||
MIRT684640 | PDE4C | phosphodiesterase 4C | 2 | 2 | ||||||||
MIRT689722 | ATXN2 | ataxin 2 | 2 | 2 | ||||||||
MIRT693594 | SLC39A1 | solute carrier family 39 member 1 | 2 | 2 | ||||||||
MIRT704745 | CDKN2B | cyclin dependent kinase inhibitor 2B | 2 | 2 | ||||||||
MIRT712779 | ZNF154 | zinc finger protein 154 | 2 | 2 | ||||||||
MIRT718118 | OTOF | otoferlin | 2 | 2 | ||||||||
MIRT720115 | SAMD4A | sterile alpha motif domain containing 4A | 2 | 2 | ||||||||
MIRT720275 | EIF1AD | eukaryotic translation initiation factor 1A domain containing | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|